Gerard Brett

Gerard Brett is the Senior Vice President leading IQVIA Biotech and Strategic Solutions in the Japan-Asia Pacific (JAPAC) region. In this capacity, he is responsible for IQVIA’s specialized clinical development services for the biotech sector, therapeutic strategy, feasibility, and the Centers of Excellence across JAPAC.

Gerard has a wealth of experience at IQVIA that includes leading R&DS sales in JAPAC and playing a pivotal role in Japan’s Contract Sales Organization (CSO), the largest CSO in the country. His leadership and strategic vision have been instrumental in driving the success of IQVIA's initiatives in the region.

Prior to joining IQVIA, Gerard worked with Mochida Pharmaceutical and Mitsubishi Chemical Japan, where he gained valuable experience in the pharmaceutical and chemical industries. Based in Tokyo, Gerard has lived in Japan for more than 30 years, bringing a deep understanding of the local market and culture to his role.

Originally from Ireland, Gerard holds a degree in Applied Sciences. His diverse background and extensive experience make him a key leader in the biotech and pharmaceutical sectors in the JAPAC region.

LinkedIn